Insider · CIK 0001585001

Yeshwant Krishna

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001585001

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	PBLSParabilis Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.2K sh	—	—	20,215
2025-07-25	Verve Therapeutics, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−6.11M sh	—	—	0
2025-07-25	Verve Therapeutics, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−4.26M sh	—	—	0
2025-07-25	Verve Therapeutics, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−1.8M sh	—	—	0
2025-07-25	Verve Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−136K sh	—	—	0
2025-07-25	Verve Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−42.2K sh	—	—	0
2025-06-05	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+42.2K sh	—	—	42,200
2024-06-26	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+136K sh	—	—	136,139
2023-12-01	Verve Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.8M sh	$10.00	+$18M	1,800,000
2023-11-09	EQRx, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−101K sh	—	—	0
2023-06-15	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+26.6K sh	—	—	26,642
2022-11-04	Verve Therapeutics, Inc.J Other	Director, 10% Owner	JOther	−48.6K sh	—	—	6,108,442
2022-11-04	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−47.7K sh	$31.12	−$1.48M	4,260,940
2022-11-04	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−650 sh	$31.99	−$20.8K	4,260,290
2022-11-04	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−243 sh	$32.90	−$7,994.7	4,260,047
2022-11-03	Verve Therapeutics, Inc.J Other	Director, 10% Owner	JOther	−49.6K sh	—	—	6,157,025
2022-11-03	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−22.3K sh	$32.32	−$720K	4,335,919
2022-11-03	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−25.5K sh	$33.14	−$846K	4,310,385
2022-11-03	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−1,755 sh	$33.84	−$59.4K	4,308,630
2022-11-02	Verve Therapeutics, Inc.J Other	Director, 10% Owner	JOther	−28.7K sh	—	—	6,206,594
2022-11-02	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−9,350 sh	$34.78	−$325K	4,377,500
2022-11-02	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−10.4K sh	$36.28	−$376K	4,367,128
2022-11-02	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−8,930 sh	$36.77	−$328K	4,358,198
2022-11-01	Verve Therapeutics, Inc.J Other	Director, 10% Owner	JOther	−32K sh	—	—	6,235,245
2022-11-01	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−29.3K sh	$36.69	−$1.08M	4,389,487
2022-11-01	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−2,377 sh	$37.82	−$89.9K	4,387,110
2022-11-01	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−260 sh	$38.64	−$10K	4,386,850
2022-10-31	Verve Therapeutics, Inc.J Other	Director, 10% Owner	JOther	−53.7K sh	—	—	6,267,208
2022-10-31	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−23.7K sh	$37.91	−$900K	4,448,777
2022-10-31	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−23.3K sh	$38.94	−$906K	4,425,502
2022-10-31	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−6,601 sh	$40.16	−$265K	4,418,901
2022-10-31	Verve Therapeutics, Inc.S Sale	Director, 10% Owner	SSale	−88 sh	$40.64	−$3,576.716	4,418,813
2022-09-30	EQRx, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,010
2022-06-09	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+15.5K sh	—	—	15,500
2021-06-21	Verve Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+6.32M sh	—	—	6,320,905
2021-06-21	Verve Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+4.03M sh	—	—	4,029,244
2021-06-21	Verve Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+443K sh	—	—	4,472,509
2021-06-21	Verve Therapeutics, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−58.5M sh	—	—	0
2021-06-21	Verve Therapeutics, Inc.Series A-2 Preferred StockC Conversion	Director, 10% Owner	CConversion	−37.3M sh	—	—	0
2021-06-21	Verve Therapeutics, Inc.Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−4.1M sh	—	—	0
2018-07-31	Foundation Medicine, Inc.U Disposition from Tender	Director	UDisposition from Tender	−5,786 sh	$137.00	−$793K	0
2017-08-08	Foundation Medicine, Inc.S Sale	Director	SSale	−4,800 sh	$40.01	−$192K	5,786
2017-08-04	Foundation Medicine, Inc.S Sale	Director	SSale	−18.1K sh	$36.85	−$666K	5,786
2017-08-04	Foundation Medicine, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+13.4K sh	$24.21	+$324K	19,171
2017-08-04	Foundation Medicine, Inc.F Tax Payment	Director	FTax Payment	−8,585 sh	$37.75	−$324K	10,586
2017-08-04	Foundation Medicine, Inc.Common StockM Exercise/Conversion	Director	MExercise/Conversion	−13.4K sh	—	—	0
2017-06-20	Foundation Medicine, Inc.A Award	Director	AAward	+5,786 sh	$40.05	+$232K	23,858
2016-06-16	Foundation Medicine, Inc.A Award	Director	AAward	+12.1K sh	$19.93	+$241K	18,072
2015-06-18	Foundation Medicine, Inc.A Award	Director	AAward	+5,997 sh	$32.23	+$193K	5,997
2015-06-15	Foundation Medicine, Inc.S Sale	Director	SSale	−114K sh	$32.33	−$3.7M	0

Recent filings

Accepted (ET)
Jun 114
Yeshwant Krishna0001193125-26-267797
SEC(opens sec.gov)
Jul 284
Yeshwant Krishna0000950170-25-099263
SEC(opens sec.gov)
Jun 64
Yeshwant Krishna0000950170-25-083226
SEC(opens sec.gov)
Jun 284
Yeshwant Krishna0000950170-24-078786
SEC(opens sec.gov)
Dec 54
Yeshwant Krishna0000950170-23-068199
SEC(opens sec.gov)
Nov 94
Yeshwant Krishna0000899243-23-020300
SEC(opens sec.gov)
Jun 204
Yeshwant Krishna0001209191-23-038470
SEC(opens sec.gov)
Nov 84
Yeshwant Krishna0000899243-22-035380
SEC(opens sec.gov)
Nov 44
Yeshwant Krishna0000899243-22-035228
SEC(opens sec.gov)

Companies

Address

C/O PARABILIS MEDICINES, INC. 30 ACORN PARK DRIVE, 6TH FLOOR

CAMBRIDGE, MA, 02140